Register now to join thought leaders from GSK, ISGlobal, Oxford University, PATH, Sanaria, WHO, and other institutions in a discussion of:
- Lessons Learned from a Vaccine without a Dual Market -- from RTS,S Research and Development to Implementation and Distribution
- Future Malaria Vaccine R&D Consideration
See the announcement for more details and links for agenda and registration.
- Page :
- 1
There are no replies made for this post yet.